Endovascular Expansion

in Future Directions in Vascular Surgery

Applied

Type

Modification

Confidence

92%

Created

Apr 14, 2026

Evidence

1 source

Rationale

The existing citation esvs 2019 aaa supports the claim that EVAR/TEVAR/FEVAR/BEVAR/PMEG are now standard for most aneurysms. The ESVS 2024 guideline (PMID 38307694) directly supersedes the 2019 guideline for this same claim. Per the stale guideline replacement instructions, the stale citation has been replaced with the newer ESVS. Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. Eur J Vasc Endovasc Surg. 2024. PMID: 38307694. DOI: 10.1016/j.ejvs.2023.11.002. rather than co-citing both, as they support the same claim and there is no historical context requiring retention of the older reference. All other content and citations remain unchanged.

Evidence

ESVS. Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. Eur J Vasc Endovasc Surg. 2024. PMID: 38307694. DOI: 10.1016/j.ejvs.2023.11.002.
Verified source
PubMedDOI

Content Changes

* endovascular aneurysm repair (EVAR), thoracic endovascular aortic repair (TEVAR), FEVAR, BEVAR [@oderich2017], PMEG [@katsargyris2017] now standard for most aneurysms [@esvs2019-aaa][@esvs2024-editors] (see [[abdominal aortic aneurysm (AAA)]] and [[TAAA]]).
* Complex aortic repairs increasingly endovascular, with open reserved for select cases [@esc2014].
* SFA and iliac interventions dominated by **drug-coated balloons (DCB)** [@tepe2015], **drug-eluting stents (DES)** [@dake2011], and bioresorbable scaffolds (see [[peripheral arterial disease (PAD)]]) [@esc2017].
Go to section in textbookDispute / Submit evidenceAll updates